© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 23, 1777-1780,
December 6, 1995
© 1995 Oxford University Press
Helicobacter pylori and Atrophic Gastritis: Importance of the cagA Status
Department of Gastroenterology, Free University Hospital Amsterdam, The Netherlands
Division of Infectious Diseases, Vanderbilt University School of Medicine and Department of Veterans Affairs Medical Center Nashville, TN.
Division of Infectious Diseases, Vanderbilt University School of Medicine and Department of Veterans Affairs Medical Center Nashville, TN.
Correspondence to: E. J. Kuipers, M.D., Department of Gastroenterology, Free University Hospital, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
Background: Infection with Helicobacter pylori is a major risk factor for the development of atrophic gastritis and gastric cancer. H. pylori strains can differ with respect to the presence of cagA (cytotoxin-associated gene A), a gene encoding a high-molecular-weight immunodominant antigen. H. pylori strains possessing cagA have been associated with enhanced induction of acute gastric inflammation. Purpose: We investigated the relationship between cagA status and the development of atrophic gastritis in a cohort of subjects infected with H. pylori. Methods: Gastrointestinal endoscopy with biopsy sampling was used to study the natural history of gastritis in 58 subjects infected with H. pylori. Biopsy specimens were obtained before and after a mean follow-up period of Hi years (range, 10–13 years). The cagA status of each individual was determined at the follow-up visit with the use of an enzyme-linked immunosorbent assay designed to detect the presence of serum immunoglobulin G directed against the CagA protein. Two-sided Fisher's exact tests, McNemar's tests, Student's t tests, and Wilcoxon sum rank tests were used to analyze the data. Results: Twenty-four (41%) of the 58 evaluated subjects had serum antibodies against CagA (i.e., they were cagA positive), and 34 subjects were cagA negative. At the initial visit, moderate to severe atrophic gastritis was observed in eight (33%) of the cagA-positive subjects and in six (18%) of the cagA-negative subjects. At that time, positive cagA status and gastric atrophy were not significantly related (P =.22; Fisher's exact test; odds ratio [OR] 2.33; 95% confidence interval [CI] = 0.58–9.65). During follow-up, 16 (36%) of the 44 initially atrophy-negative subjects developed atrophic gastritis (eight [50%] of 16 cagA-positive subjects versus eight [29%] of 28 cagA-negative subjects; P =.20, Fisher's exact test; relative risk [RR] = 1.75; 95% CI = 0.82–3.76). In six of these 16 subjects (five cagA positive versus one cagA negative), atrophic gastritis was accompanied by the development of intestinal metaplasia (i.e., a change in the type of specialized cells present) (P =.02; Fisher's exact test; RR = 9.06; 95% CI = 1.16–71.0). One of the initially atrophy-negative, cagA-positive subjects developed early gastric cancer. Four (29%) of the 14 subjects initially diagnosed with atrophic gastritis showed regression of atrophy during follow-up (one cagA positive and three cagA negative). Therefore, at the end of follow-up, 15 (62%) of the 24 cagA-positive subjects had atrophic gastritis compared with 11 (32%) of the 34 cagA-negative subjects (P =.02; Fisher's exact test; OR = 3.48; 95% CI = 1.02–12.18). Conclusion: Infection with cagA-positive H. pylori strains is associated with an increased risk for the eventual development of atrophic gastritis and intestinal metaplasia.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Gao, M. N. Weck, A. Michel, M. Pawlita, and H. Brenner Association between Chronic Atrophic Gastritis and Serum Antibodies to 15 Helicobacter pylori Proteins Measured by Multiplex Serology Cancer Res., April 1, 2009; 69(7): 2973 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Peek Jr Review: Prevention of gastric cancer: When is treatment of Helicobacter pylori warranted? Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 19 - 31. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Ohnishi, H. Yuasa, S. Tanaka, H. Sawa, M. Miura, A. Matsui, H. Higashi, M. Musashi, K. Iwabuchi, M. Suzuki, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse PNAS, January 22, 2008; 105(3): 1003 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wen, D. Velin, C. P. Felley, L. Du, P. Michetti, and Q. Pan-Hammarstrom Expression of Helicobacter pylori Virulence Factors and Associated Expression Profiles of Inflammatory Genes in the Human Gastric Mucosa Infect. Immun., November 1, 2007; 75(11): 5118 - 5126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Plummer, L.-J. van Doorn, S. Franceschi, B. Kleter, F. Canzian, J. Vivas, G. Lopez, D. Colin, N. Munoz, and I. Kato Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions J Natl Cancer Inst, September 5, 2007; 99(17): 1328 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen and M. J. Blaser Inverse Associations of Helicobacter pylori With Asthma and Allergy Arch Intern Med, April 23, 2007; 167(8): 821 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Panayotopoulou, D. N. Sgouras, K. Papadakos, A. Kalliaropoulos, G. Papatheodoridis, A. F. Mentis, and A. J. Archimandritis Strategy To Characterize the Number and Type of Repeating EPIYA Phosphorylation Motifs in the Carboxyl Terminus of CagA Protein in Helicobacter pylori Clinical Isolates J. Clin. Microbiol., February 1, 2007; 45(2): 488 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G M Naylor, T Gotoda, M Dixon, T Shimoda, L Gatta, R Owen, D Tompkins, and A Axon Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients Gut, November 1, 2006; 55(11): 1545 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. S. Algood and T. L. Cover Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses Clin. Microbiol. Rev., October 1, 2006; 19(4): 597 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Kusters, A. H. M. van Vliet, and E. J. Kuipers Pathogenesis of Helicobacter pylori Infection Clin. Microbiol. Rev., July 1, 2006; 19(3): 449 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bhat, J. Gaensbauer, R. M. Peek, K. Bloch, K.-T. Tham, M. J. Blaser, and G. Perez-Perez Local and Systemic Immune and Inflammatory Responses to Helicobacter pylori Strains Clin. Vaccine Immunol., December 1, 2005; 12(12): 1393 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mueller, S. Falkow, and M. R. Amieva Helicobacter pylori and Gastric Cancer: What can be Learned by Studying the Response of Gastric Epithelial Cells to the Infection? Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1859 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Higashi, K. Yokoyama, Y. Fujii, S. Ren, H. Yuasa, I. Saadat, N. Murata-Kamiya, T. Azuma, and M. Hatakeyama EPIYA Motif Is a Membrane-targeting Signal of Helicobacter pylori Virulence Factor CagA in Mammalian Cells J. Biol. Chem., June 17, 2005; 280(24): 23130 - 23137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ghose, G. I. Perez-Perez, L. J. van Doorn, M. G. Dominguez-Bello, and M. J. Blaser High Frequency of Gastric Colonization with Multiple Helicobacter pylori Strains in Venezuelan Subjects J. Clin. Microbiol., June 1, 2005; 43(6): 2635 - 2641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Wu, P.-Y. Chou, C.-T. Hu, Z.-C. Liu, C.-Y. Lin, Y.-H. Tseng, and N.-T. Lin Clinical Relevance of the vacA, iceA, cagA, and flaA Genes of Helicobacter pylori Strains Isolated in Eastern Taiwan J. Clin. Microbiol., June 1, 2005; 43(6): 2913 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ceelen, A. Decostere, G. Verschraegen, R. Ducatelle, and F. Haesebrouck Prevalence of Helicobacter pullorum among Patients with Gastrointestinal Disease and Clinically Healthy Persons J. Clin. Microbiol., June 1, 2005; 43(6): 2984 - 2986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Higashi, A. Nakaya, R. Tsutsumi, K. Yokoyama, Y. Fujii, S. Ishikawa, M. Higuchi, A. Takahashi, Y. Kurashima, Y. Teishikata, et al. Helicobacter pylori CagA Induces Ras-independent Morphogenetic Response through SHP-2 Recruitment and Activation J. Biol. Chem., April 23, 2004; 279(17): 17205 - 17216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-K. Vilaichone, V. Mahachai, C. Kositchaiwat, D. Y. Graham, and Y. Yamaoka Relation between Seroreactivity to Low-Molecular-Weight Helicobacter pylori-Specific Antigens and Disease Presentation Clin. Vaccine Immunol., November 1, 2003; 10(6): 1025 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Simon, E. S. Hudes, and G. I. Perez-Perez Relation of Serum Ascorbic Acid to Helicobacter pylori Serology in US Adults: the Third National Health and Nutrition Examination Survey J. Am. Coll. Nutr., August 1, 2003; 22(4): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Risch Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity J Natl Cancer Inst, July 2, 2003; 95(13): 948 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tsutsumi, H. Higashi, M. Higuchi, M. Okada, and M. Hatakeyama Attenuation of Helicobacter pylori CagA{middle dot}SHP-2 Signaling by Interaction between CagA and C-terminal Src Kinase J. Biol. Chem., January 31, 2003; 278(6): 3664 - 3670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Blaser Polymorphic Bacteria Persisting in Polymorphic Hosts: Assessing Helicobacter pylori-Related Risks for Gastric Cancer J Natl Cancer Inst, November 20, 2002; 94(22): 1662 - 1663. [Full Text] [PDF]
|
|
|
|
|
|
C. Figueiredo, J. C. Machado, P. Pharoah, R. Seruca, S. Sousa, R. Carvalho, A. F. Capelinha, W. Quint, C. Caldas, L.-J. van Doorn, et al. Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma J Natl Cancer Inst, November 20, 2002; 94(22): 1680 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Higashi, R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites PNAS, October 29, 2002; 99(22): 14428 - 14433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. D. Groves, G. Perez-Perez, L. Zhang, W.-c. You, S. R. Lipsitz, M. H. Gail, J. F. Fraumeni Jr., and M. J. Blaser Serum Antibodies to Helicobacter pylori and the CagA Antigen Do Not Explain Differences in the Prevalence of Precancerous Gastric Lesions in Two Chinese Populations with Contrasting Gastric Cancer Rates Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1091 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takata, R. Aras, D. Tavakoli, T. Ando, A. Z. Olivares, and M. J. Blaser Phenotypic and genotypic variation in methylases involved in type II restriction-modification systems in Helicobacter pylori Nucleic Acids Res., June 1, 2002; 30(11): 2444 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study Gut, June 1, 2002; 50(6): 779 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Y. Nomura, G. I. Perez-Perez, J. Lee, G. Stemmermann, and M. J. Blaser Relation between Helicobacter pylori cagA Status and Risk of Peptic Ulcer Disease Am. J. Epidemiol., June 1, 2002; 155(11): 1054 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rad, M. Gerhard, R. Lang, M. Schoniger, T. Rosch, W. Schepp, I. Becker, H. Wagner, and C. Prinz The Helicobacter pylori Blood Group Antigen-Binding Adhesin Facilitates Bacterial Colonization and Augments a Nonspecific Immune Response J. Immunol., March 15, 2002; 168(6): 3033 - 3041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Everhart, D. Kruszon-Moran, and G. Perez-Perez Reliability of Helicobacter pylori and CagA Serological Assays Clin. Vaccine Immunol., March 1, 2002; 9(2): 412 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R.E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma Carcinogenesis, March 1, 2002; 23(3): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ando, R. M. Peek, D. Pride, S. M. Levine, T. Takata, Y.-C. Lee, K. Kusugami, A. van der Ende, E. J. Kuipers, J. G. Kusters, et al. Polymorphisms of Helicobacter pylori HP0638 Reflect Geographic Origin and Correlate with cagA Status J. Clin. Microbiol., January 1, 2002; 40(1): 239 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Cox, C. L. Clayton, T. Tomita, D. M. Wallace, P. A. Robinson, and J. E. Crabtree cDNA Array Analysis of cag Pathogenicity Island-Associated Helicobacter pylori Epithelial Cell Response Genes Infect. Immun., November 1, 2001; 69(11): 6970 - 6980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Yamaji, T Mitsushima, H Ikuma, M Okamoto, H Yoshida, T Kawabe, Y Shiratori, K Saito, K Yokouchi, and M Omata Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects Gut, September 1, 2001; 49(3): 335 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mizushima, T. Sugiyama, Y. Komatsu, J. Ishizuka, M. Kato, and M. Asaka Clinical Relevance of the babA2 Genotype of Helicobacter pylori in Japanese Clinical Isolates J. Clin. Microbiol., July 1, 2001; 39(7): 2463 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Kidd, A J Lastovica, J C Atherton, and J A Louw Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates Gut, July 1, 2001; 49(1): 11 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Figueiredo, W. Quint, N. Nouhan, H. van den Munckhof, P. Herbrink, J. Scherpenisse, W. de Boer, P. Schneeberger, G. Perez-Perez, M. J. Blaser, et al. Assessment of Helicobacter pylori vacA and cagA Genotypes and Host Serological Response J. Clin. Microbiol., April 1, 2001; 39(4): 1339 - 1344. [Abstract] [Full Text]
|
|
|
|
|
|
B. D. Gold, L.-J. van Doorn, J. Guarner, M. Owens, D. Pierce-Smith, Q. Song, L. Hutwagner, P. M. Sherman, O. L. de Mola, and S. J. Czinn Genotypic, Clinical, and Demographic Characteristics of Children Infected with Helicobacter pylori J. Clin. Microbiol., April 1, 2001; 39(4): 1348 - 1352. [Abstract] [Full Text]
|
|
|
|
 |
|
 T M Peters, R J Owen, E Slater, R Varea, E L Teare, and S Saverymuttu Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia J. Clin. Pathol., March 1, 2001; 54(3): 219 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Limburg, Y.-L. Qiao, S. D. Mark, G.-Q. Wang, G. I. Perez-Perez, M. J. Blaser, Y.-P. Wu, X.-N. Zou, Z.-W. Dong, P. R. Taylor, et al. Helicobacter pylori Seropositivity and Subsite-Specific Gastric Cancer Risks in Linxian, China J Natl Cancer Inst, February 7, 2001; 93(3): 226 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ley, A. Mohar, J. Guarner, R. Herrera-Goepfert, L. S. Figueroa, D. Halperin, and J. Parsonnet Screening Markers for Chronic Atrophic Gastritis in Chiapas, Mexico Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 107 - 112. [Abstract] [Full Text]
|
|
|
|
|
|
D. T. Pride, R. J. Meinersmann, and M. J. Blaser Allelic Variation within Helicobacter pylori babA and babB Infect. Immun., February 1, 2001; 69(2): 1160 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Nogueira, C. Figueiredo, F. Carneiro, A. Taveira Gomes, R. Barreira, P. Figueira, C. Salgado, L. Belo, A. Peixoto, J. C. Bravo, et al. Helicobacter pylori Genotypes May Determine Gastric Histopathology Am. J. Pathol., February 1, 2001; 158(2): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Touati, M. Hofnung, J.-M. Thiberge, V. Michel, A. Labigne, and P. J. Jenks Short-term infection with Helicobacter pylori and 1 week exposure to metronidazole does not enhance gastric mutation frequency in transgenic mice J. Antimicrob. Chemother., December 1, 2000; 46(6): 987 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Yahav, A. Fradkin, B. Weisselberg, A. Diver-Haver, H. Shmuely, and A. Jonas Relevance of CagA Positivity to Clinical Course of Helicobacter pylori Infection in Children J. Clin. Microbiol., October 1, 2000; 38(10): 3534 - 3537. [Abstract] [Full Text]
|
|
|
|
|
|
T. Ando, G. I. Perez-Perez, K. Kusugami, M. Ohsuga, K. C. Bloch, and M. J. Blaser Anti-CagA Immunoglobulin G Responses Correlate with Interleukin-8 Induction in Human Gastric Mucosal Biopsy Culture Clin. Vaccine Immunol., September 1, 2000; 7(5): 803 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Yoshimura, T Shimoyama, M Tanaka, Y Sasaki, S Fukuda, and A Munakata Gastric mucosal inflammation and epithelial cell turnover are associated with gastric cancer in patients with Helicobacter pylori infection J. Clin. Pathol., July 1, 2000; 53(7): 532 - 536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B E Schenk, E J Kuipers, G F Nelis, E Bloemena, J C Thijs, P Snel, A E G Luckers, E C Klinkenberg-Knol, H P M Festen, P P Viergever, et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy Gut, May 1, 2000; 46(5): 615 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Oksanen, P Sipponen, R Karttunen, A Miettinen, L Veijola, S Sarna, and H Rautelin Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy Gut, April 1, 2000; 46(4): 460 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L-J van Doorn, P M Schneeberger, N Nouhan, A P Plaisier, W G V Quint, and W A de Boer Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment Gut, March 1, 2000; 46(3): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I Nilsson, S Lindgren, S Eriksson, and T Wadstrom Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease Gut, March 1, 2000; 46(3): 410 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kato, T. Sugiyama, M. Kudo, K. Ohnuma, K. Ozawa, K. Iinuma, M. Asaka, and M. J. Blaser CagA Antibodies in Japanese Children with Nodular Gastritis or Peptic Ulcer Disease J. Clin. Microbiol., January 1, 2000; 38(1): 68 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
R. M. Peek Jr., M. J. Blaser, D. J. Mays, M. H. Forsyth, T. L. Cover, S. Y. Song, U. Krishna, and J. A. Pietenpol Helicobacter pylori Strain-specific Genotypes and Modulation of the Gastric Epithelial Cell Cycle Cancer Res., December 1, 1999; 59(24): 6124 - 6131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gerhard, N. Lehn, N. Neumayer, T. Boren, R. Rad, W. Schepp, S. Miehlke, M. Classen, and C. Prinz Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin PNAS, October 26, 1999; 96(22): 12778 - 12783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Kidd, A J Lastovica, J C Atherton, and J A Louw Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? Gut, October 1, 1999; 45(4): 499 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-J. van Doorn, C. Figueiredo, R. Sanna, M. J. Blaser, and W. G. V. Quint Distinct Variants of Helicobacter pylori cagA Are Associated with vacA Subtypes J. Clin. Microbiol., July 1, 1999; 37(7): 2306 - 2311. [Abstract] [Full Text]
|
|
|
|
|
|
N. E. M. van Doorn, F. Namavar, L.-J. van Doorn, Z. Durrani, E. J. Kuipers, and C. M. J. E. Vandenbroucke-Grauls Analysis of vacA, cagA, and IS605 Genotypes and Those Determined by PCR Amplification of DNA between Repetitive Sequences of Helicobacter pylori Strains Isolated from Patients with Nonulcer Dyspepsia or Mucosa-Associated Lymphoid Tissue Lymphoma J. Clin. Microbiol., July 1, 1999; 37(7): 2348 - 2349. [Abstract] [Full Text]
|
|
|
|
|
|
N. E. M. van Doorn, F. Namavar, M. Sparrius, J. Stoof, E. P. van Rees, L.-J. van Doorn, and C. M. J. E. Vandenbroucke-Grauls Helicobacter pylori-Associated Gastritis in Mice is Host and Strain Specific Infect. Immun., June 1, 1999; 67(6): 3040 - 3046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Nardone, S Staibano, A Rocco, E Mezza, F P D'Armiento, L Insabato, A Coppola, G Salvatore, A Lucariello, N Figura, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis Gut, June 1, 1999; 44(6): 789 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Maeda, H Yoshida, T Ikenoue, K Ogura, F Kanai, N Kato, Y Shiratori, and M Omata Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates Gut, March 1, 1999; 44(3): 336 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P J Jenks, F Megraud, and A Labigne Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island Gut, December 1, 1998; 43(6): 752 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yamaoka, T. Kodama, D. Y. Graham, and K. Kashima Comparison of Four Serological Tests To Determine the CagA or VacA Status of Helicobacter pylori Strains J. Clin. Microbiol., November 1, 1998; 36(11): 3433 - 3434. [Abstract] [Full Text]
|
|
|
|
|
|
L.-J. van Doorn, C. Figueiredo, R. Sanna, S. Pena, P. Midolo, E. K. W. Ng, J. C. Atherton, M. J. Blaser, and W. G. V. Quint Expanding Allelic Diversity of Helicobacter pylori vacA J. Clin. Microbiol., September 1, 1998; 36(9): 2597 - 2603. [Abstract] [Full Text]
|
|
|
|
|
|
N Figura, C Vindigni, A Covacci, L Presenti, D Burroni, R Vernillo, T Banducci, F Roviello, D Marrelli, M Biscontri, et al. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage Gut, June 1, 1998; 42(6): 772 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. van der Ende, Z.-J. Pan, A. Bart, R. W. M. van der Hulst, M. Feller, S.-D. Xiao, G. N. J. Tytgat, and J. Dankert cagA-Positive Helicobacter pylori Populations in China and The Netherlands Are Distinct Infect. Immun., May 1, 1998; 66(5): 1822 - 1826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Faller, H Steininger, J Kranzlein, H Maul, T Kerkau, J Hensen, E G Hahn, and T Kirchner Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis Gut, November 1, 1997; 41(5): 619 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Higashi, R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein Science, January 25, 2002; 295(5555): 683 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Gupta, D. B. Polk, U. Krishna, D. A. Israel, F. Yan, R. N. DuBois, and R. M. Peek Jr. Activation of Peroxisome Proliferator-activated Receptor gamma Suppresses Nuclear Factor kappa B-mediated Apoptosis Induced by Helicobacter pylori in Gastric Epithelial Cells J. Biol. Chem., August 10, 2001; 276(33): 31059 - 31066. [Abstract] [Full Text] [PDF]
|
|